Germline PAX5 deletions have not yet been described in patients with BCP-ALL but considering the recurrence of somatic PAX5 deletions in BCP-ALL, the germline deletion in our patient likely contributed to leukemia development. This evidence concerns the gene PAX5 and leukemia.